BioCentury
ARTICLE | Company News

Inhale, J&J, Sheffield deal

May 6, 2002 7:00 AM UTC

INHL expanded its 2000 deal with JNJ's Johnson & Johnson Pharmaceutical R&D LLC subsidiary to develop supercritical fluid-based compounds. As expanded, INHL's Bradford Particle Design Ltd. subsidiary will study the use of its supercritical fluid technology in chemical manufacturing. INHL retains rights to develop and market the technology. INHL and JNJ also are collaborating to develop inhaleable small molecules (see BioCentury, Oct. 15, 2001). ...